Presence of platelet-associated anti-glycoprotein (GP)VI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 8, 2009, Pages 1373-1383

  Akiyama, M ^a   Kashiwagi, H ^a   Todo, K ^b   Moroi, M ^c   Berndt, M C ^d   Kojima, H ^e   Kanakura, Y ^a   Tomiyama, Yoshi ^a,f  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^f OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

GPVI deficiency; Immune thrombocytopenic purpura; Platelet associated autoantibody

Indexed keywords

AUTOANTIBODY; COLLAGEN; FC RECEPTOR; GLYCOPROTEIN VI; GLYCOPROTEIN VI AUTOANTIBODY; IMMUNOGLOBULIN G; INTEGRIN; INTEGRIN ALPHA2B BETA3; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ANIMAL CELL; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BLEEDING; CASE REPORT; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GLYCOPROTEIN VI DEFICIENCY; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REMISSION; SCHOOL CHILD; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA;

ADULT; AUTOANTIBODIES; BLOOD PLATELETS; CHILD; EPITOPES; FEMALE; HUMANS; PLATELET MEMBRANE GLYCOPROTEINS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 68049111684     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03510.x     Document Type: Article

References (40)

1. Nieswandt B, Watson SP. Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003; 102: 449-61.
2. Moroi M, Jung SM. Platelet glycoprotein. VI: Its structure and function. Thromb Res 2004; 114: 221-33.
3. Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin αIIbβ3 signaling in platelets. J Thromb Haemost 2005; 3: 1752-62.
4. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-20.
5. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein. VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440-5.
6. Ryo R, Yoshida A, Sugano W, Yasunaga M, Nakayama K, Saigo K, Adachi M, Yamaguchi N, Okuma M. Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. Am J Hematol 1992; 39: 25-31.
7. Arai M, Yamamoto N, Moroi M, Akamatsu N, Fukutake K, Tanoue K. Platelets with 10% of the normal amount of glycoprotein. VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol 1995; 89: 124-30.
8. Takahashi H, Moroi M. Antibody against platelet membrane glycoprotein. VI in a patient with systemic lupus erythematosus. Am J Hematol 2001; 67: 262-7.
9. Nurden P, Jandrot-Perrus M, CombriéR, Winckler J, Arocas V, Lecut C, Pasquet JM, Kunicki TJ, Nurden AT. Severe deficiency of glycoprotein. VI in a patient with gray platelet syndrome. Blood 2004; 104: 107-14.
10. Boylan B, Chen H, Rathore V, Paddock C, Salacz M, Friedman KD, Curtis BR, Stapleton M, Newman DK, Kahn ML, Newman PJ. Anti-GPVI-associated ITP: An acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface. Blood 2004; 104: 1350-5.
11. Kojima H, Moroi M, Jung SM, Goto S, Tamura N, Kozuma Y, Suzukawa K, Nagasawa T. Characterization of a patient with glycoprotein (GP). VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration. J Thromb Haemost 2006; 4: 2433-42.
12. Gardiner EE, Al-Tamimi M, Mu FT, Karunakaran D, Thom JY, Moroi M, Andrews RK, Berndt MC, Baker RI. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. J Thromb Haemost 2008; 6: 1175-82.
13. Freson K, Hermans C, Thys C, van Geet C. GPVI mutation and absent platelet collagen activation in a patient with a bleeding disorder. Blood 2007; 110: 627a (abstract).
14. Jandrot-Perrus M, Dumont B, Lasne D, Rothschild C, Grandchamp B, Ajzenberg N. Absent collagen-induced platelet activation in a patient double heterozygous for two GPVI mutations. Blood 2008; 112: 39 (abstract).
15. Nurden P, Tandon N, Takizawa H, Gong X, Conception A, Morel D, Merville P, Loya S, Jandrot-Perrus M, Nurden AT. Regulation of an acquired inhibitor to the GPVI platelet collagen receptor in a patient with an autoimmune syndrome and kidney disease. Blood 2008; 112: 1168 (abstract).
16. Arthur JF, Dunkley S, Andrews RK. Platelet glycoprotein. VI-related clinical defects. Br J Haematol 2007; 139: 363-72.
17. Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein. VI in mice. J Exp Med 2001; 193: 459-69.
18. Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B. Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 2007; 110: 529-35.
19. Takayama H, Hosaka Y, Nakayama K, Shirakawa K, Naitoh K, Matsusue T, Shinozaki M, Honda M, Yatagai Y, Kawahara T, Hirose J, Yokoyama T, Kurihara M, Furusako S. A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex. J Clin Invest 2008; 118: 1785-95.
20. Boylan B, Berndt MC, Kahn ML, Newman PJ. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood 2006; 108: 908-14.
21. Moroi M, Mizuguchi J, Kawashima S, Nagamatsu M, Miura Y, Nakagaki T, Ito K, Jung SM. A new monoclonal antibody, mAb 204-11, that influences the binding of platelet GPVI to fibrous collagen. Thromb Haemost 2003; 89: 996-1003.
22. Arthur JF, Shen Y, Kahn ML, Berndt MC, Andrews RK, Gardiner EE. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem 2007; 282: 30434-41.
23. Jung SM, Ohnuma M, Watanabe N, Sonoda M, Handa M, Moroi M. Analyzing the mechanism of Rap1 activation in platelets: Rap1 activation is related to the release reaction mediated through the collagen receptor GPVI. Thromb Res 2006; 118: 509-21.
24. Honda S, Tomiyama Y, Shiraga M, Tadokoro S, Takamatsu J, Saito H, Kurata Y, Matsuzawa Y. A two-amino acid insertion in the Cys146-Cys167 loop of the αIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding. J Clin Invest 1998; 102: 1183-92.
25. Matsumoto Y, Takizawa H, Gong X, Le S, Lockyer S, Okuyama K, Tanaka M, Yoshitake M, Tandon NN, Kambayashi J. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization. Thromb Res 2007; 119: 319-29.
26. Kosugi S, Tomiyama Y, Honda S, Kato H, Kiyoi T, Kashiwagi H, Kurata Y, Matsuzawa Y. Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb. Blood 2001; 98: 1819-27.
27. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanayama Y, Kurata Y, Matsuzawa Y. Identification of molecular defects in a subject with type I CD36 deficiency. Blood 1994; 83: 3545-52.
28. Kurata Y, Hayashi S, Kosugi S, Kashiwagi H, Tomiyama Y, Kanayama Y, Matsuzawa Y. Elevated platelet-associated IgG in SLE patients due to anti-platelet autoantibody: Differentiation between autoantibodies and immune complexes by ether elution. Br J Haematol 1993; 85: 723-8.
29. Kiyoi T, Tomiyama Y, Honda S, Tadokoro S, Arai M, Kashiwagi H, Kosugi S, Kato H, Kurata Y, Matsuzawa Y. A naturally occurring Tyr143His αIIb mutation abolishes αIIbβ3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: Comparison with other mutations causing ligand-binding defects. Blood 2003; 101: 3485-91.
30. Tomiyama Y, Kekomäki R, McFarland J, Kunicki TJ. Antivinculin antibodies in sera of patients with immune thrombocytopenia and in sera of normal subjects. Blood 1992; 79: 161-8.
31. Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007; 5: 1530-7.
32. Kambayashi J, Shinoki N, Nakamura T, Ariyoshi H, Kawasaki T, Sakon M, Monden M. Prevalence of impaired responsiveness to epinephrine in platelets among Japanese. Thromb Res 1996; 81: 85-90.
33. Croft SA, Samani NJ, Teare MD, Hampton KK, Steeds RP, Channer KS, Daly ME. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 2001; 104: 1459-63.
34. Fujisawa K, Tani P, Pilo L, McMillan R. The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 1993; 81: 2872-7.
35. Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-izing FcγRIIa. Blood 2008; 111: 165-74.
36. McMillan R. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: Assays and epitopes. J Pediatr Hematol Oncol 2003; 25 (Suppl. 1): S57-61.
37. Matsumoto Y, Takizawa H, Nakama K, Gong X, Yamada Y, Tandon NN, Kambayashi J. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: Dissociation between anti-platelet aggregatory effect and bleeding time. Thromb Haemost 2006; 96: 167-75.
38. Li H, Lockyer S, Concepcion A, Gong X, Takizawa H, Guertin M, Matsumoto Y, Kambayashi J, Tandon NN, Liu Y. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats. Arterioscler Thromb Vasc Biol 2007; 27: 1199-205.
39. Ohlmann P, Hechler B, Ravanat C, Loyau S, Herrenschmidt N, Wanert F, Jandrot-Perrus M, Gachet C. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression. J Thromb Haemost 2008; 6: 1003-11.
40. Best D, Senis YA, Jarvis GE, Eagleton HJ, Roberts DJ, Saito T, Jung SM, Moroi M, Harrison P, Green FR, Watson SP. GPVI levels in platelets: relationship to platelet function at high shear. Blood 2003; 102: 2811-18.